Treatment of secondary CNS lymphoma using CD19-targeted chimeric antigen receptor (CAR) T cells

被引：0
|
作者：
Kathryn Kline
Tim Luetkens
Rima Koka
Michael E. Kallen
Wengen Chen
Haroon Ahmad
Destiny Omili
Thierry Iraguha
Etse Gebru
Xiaoxuan Fan
Alexis Miller
Nishanthini Dishanthan
Jillian M. Baker
Kenneth A. Dietze
Kim G. Hankey
Jean A. Yared
Nancy M. Hardy
Aaron P. Rapoport
Saurabh Dahiya
Djordje Atanackovic
机构：
[1] University of Maryland Greenebaum Comprehensive Cancer Center,Cancer Immunotherapy, Fannie Angelos Cellular Therapeutics GMP Laboratory
[2] University of Maryland School of Medicine,Department of Medicine
[3] University of Maryland,Department of Microbiology and Immunology
[4] University of Maryland School of Medicine,Department of Pathology
[5] University of Maryland School of Medicine,Diagnostic Radiology and Nuclear Medicine
[6] University of Maryland School of Medicine,Department of Neurology
[7] University of Maryland Greenebaum Comprehensive Cancer Center,Transplant and Cellular Therapy Program
[8] Stanford University,undefined
来源：
Cancer Immunology, Immunotherapy | / 73卷
关键词：
B cell lymphoma; CNS lymphoma; CAR-T cells; Neurotoxicity; T cells; Cytokines;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] RE-Treatment with CD19-Targeted CAR-T Cells for Relapse after CD19-CAR-T Cell Therapy
    Nishio, Nobuhiro
    Hamada, Motoharu
    Nishikawa, Eri
    Kawashima, Nozomu
    Narita, Atsushi
    Muramatsu, Hideki
    Wang, Kai
    Zheng, Huyong
    Chang, Jung-Li
    Takahashi, Yoshiyuki
    PEDIATRIC BLOOD & CANCER, 2021, 68
  • [32] Potent anti-leukemia activities of humanized CD19-targeted Chimeric antigen receptor T (CAR-T) cells in patients with relapsed/refractory acute lymphoblastic leukemia
    Cao, Jiang
    Wang, Gang
    Cheng, Hai
    Wei, Chen
    Qi, Kunming
    Sang, Wei
    Li Zhenyu
    Shi, Ming
    Li, Huizhong
    Qiao, Jianlin
    Pan, Bin
    Zhao, Jing
    Wu, Qingyun
    Zeng, Lingyu
    Niu, Mingshan
    Jing, Guangjun
    Zheng, Junnian
    Xu, Kailin
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (07) : 851 - 858
  • [33] CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
    Mougiakakos, Dimitrios
    Kroenke, Gerhard
    Voelkl, Simon
    Kretschmann, Sascha
    Aigner, Michael
    Kharboutli, Soraya
    Boeltz, Sebastian
    Manger, Bernhard
    Mackensen, Andreas
    Schett, Georg
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (06): : 567 - 569
  • [34] A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia
    Enblad, Gunilla
    Karlsson, Hannah
    Gammelgard, Gustav
    Wenthe, Jessica
    Lovgren, Tanja
    Amini, Rose Marie
    Wikstrom, Kristina I.
    Essand, Magnus
    Savoldo, Barbara
    Hallbook, Helene
    Hoglund, Martin
    Dotti, Gianpietro
    Brenner, Malcolm K.
    Hagberg, Hans
    Loskog, Angelica
    CLINICAL CANCER RESEARCH, 2018, 24 (24) : 6185 - 6194
  • [35] Extracellular Vesicles Expressing CD19 Antigen Improve Expansion and Efficacy of CD19-Targeted CAR-T Cells
    Zhang, Yuanyuan
    Ge, Tong
    Huang, Meijuan
    Qin, Yun
    Liu, Tianjiao
    Mu, Wei
    Wang, Gaoxiang
    Jiang, Lijun
    Li, Tongjuan
    Zhao, Lei
    Wang, Jue
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2023, 18 : 49 - 63
  • [36] Therapeutic efficacy and infectious complications of CD19-targeted chimeric antigen receptor-modified T cell immunotherapy
    Gao, Zhilin
    Lian, Yu
    Ti, Juanjuan
    Ren, Ruirui
    Ma, Liangming
    ANTI-CANCER DRUGS, 2023, 34 (04) : 551 - 557
  • [37] Chimeric antigen receptor (CAR) T cells for the treatment of allergy
    Zabel, M.
    Kratzer, B.
    Trapin, D.
    Steinberger, P.
    Pickl, W.
    ALLERGY, 2020, 75 : 128 - 129
  • [38] CD19-Targeted Chimeric Antigen Receptor T-cell Therapy for Concomitant Diffuse Large B-cell Lymphoma and Multiple Myeloma
    D'Ovidio, Tyler
    Ciccolini, Kathryn
    Kalac, Matko
    Osman, Keren
    Steinberg, Amir
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
  • [39] Radiation therapy for patients with relapsed or refractory mantle cell lymphoma undergoing CD19-targeted chimeric antigen receptor T-cell therapy
    Ababneh, Hazim S.
    Frigault, Matthew J.
    Patel, Chirayu G.
    HEMATOLOGICAL ONCOLOGY, 2024, 42 (01)
  • [40] CD30-Directed Chimeric Antigen Receptor (CAR)-T Cells for Treatment of Hodgkin Lymphoma and NonHodgkin Lymphoma in Pediatric Patients
    Hucks, George E., Jr.
    Savoldo, Barbara
    Dotti, Gianpietro
    Cheng, Catherine Joyce Arago
    Babinec, Caroline
    Kasow, Kimberly A.
    Winstead, Michael
    Patel, Arpita
    Presler, Cammie
    Grover, Natalie S.
    Morrison, J. Kaitlin
    Beaven, Anne W.
    Riches, Marcie L.
    Shea, Thomas C.
    Serody, Jonathan S.
    BLOOD, 2021, 138
12345